Infectious Diseases | Conferences | 2018 |Tokyo | Japan | Asia Pacific | Infection | Meetings | International conferences | Global Events | japan events

Theme: Emerging Innovative Treatment & Therapeutic Techniques in Infectious Disease

Infectious Diseases Meet 2018

Tentative Program

Renowned Speakers

Joseph Mathew
Postgraduate Institute of Medical Education and Research
India

Hiroshi Ohrui
Yokohama University of Pharmacy
Japan

Philip Norrie
Family Physician
Australia

Rosie D Lyles
Director of Clinical Affairs at Medline Industries,Inc
USA

Lydia Nabil Fouad Melek
Alexandria University
Egypt

Leila Azimi
Shahid Beheshti University of Medical Sciences
Iran

Tianhua Huang
Shantou University Medical College
China

Huang Wei Ling
Medical Acupuncture and Pain Management Clinic
Brazil

Magez Stefan
Vrije Universiteit Brussel
Belgium

Radwanska Magdalena
UniversitÃ© Libre de Bruxelles
Belgium

Ilya B. Tsyrlov
XENOTOX Inc
USA

Jia-Ching Shieh
Chung Shan Medical University
Taiwan

Ayoub A. Bazzaz
University of Kirkuk
Iraq

Sunil Palchaudhuri
WSU School of Medicine
USA

Shahnaz Armin
Shahid Beheshti University of Medical Sciences
Iran

Fatemeh Fallah
Tabriz University of Medical Sciences
Iran

Valeria Vanegas Segura
Los Andes University
Colombia

Zarema Obradovic
University of Sarajevo
Bosnia and Herzegovina

Saeid Maham
Shahid Beheshti University of Medical Sciences
Iran

Infectious Diseases Meet 2018

Welcome Message
Infectious Diseases Meet 2018

Dear Friends /Colleagues,

It is my great pleasure to see you in the Global Experts Meeting on “Infectious Diseases”, Tokyo, Japan September 3-4, 2018.

Infection, whether bacterial, viral, protozoal or fungal, has always been a source of suffering for patients and a burden to societies from health, financial and psychosocial perspectives.

Antibiotics have been battling bacteria and saving lives since the 1940's. However, some strains of bacteria have now become resistant to antibiotics, and they have been gaining strength and shifting the tide in their favor. Antibiotic resistance and the rise of resistant strains really put modern medicine at risk.

Ongoing research is trying to find solutions to such emerging problems, in addition to developing diagnostics and more effective therapeutics for existing infections.

I will be sharing with a talk from my own experience on “The unique features of oral and maxillofacial infections” and their management.

I am delighted to encourage medical professionals to come, ask questions, make discussions and make new collaborations.

Participants to the event, besides updating and discussing new trends in management of infectious diseases, have a unique opportunity to generate international research networks.

I cordially invite you to participate in this honourable event.

Have safe travels and see you in Tokyo.

Best wishes,

Dr Lydia N. Melek

Lecturer of Oral and Maxillofacial Surgery

Egypt

Track 01: Infectious Diseases

Infectious diseases kill more people worldwide than any other single cause. The diseases caused by germs and which may infect any part of the body are called infectious diseases. They can be spread by any means where there is a germ. They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can be spread by direct or indirect contact. Vaccination, maintenance of proper hygiene and medicines help in the prevention of infection.

Related Conferences:

8th Asia Pacific STD and Infectious Diseases Congress, November 12-13, 2018 Tokyo, Japan; Global experts meet on STD-AIDS and Infectious Diseases September 5-6, 2018 Auckland, New Zealand; 11th Global Infections Conference November 12-13, 2018 Melbourne, Australia; 10^th Euro-Global Conference on Infectious Diseases September 27-29, 2018 Rome, Italy; 14th World Congress on Infection Prevention and Control October 11-12, 2018 Moscow, Russia,World Conference on Bacteriology and Infectious Diseases August 13-14, 2018 Chicago, USA; 2nd International Conference on Sexually Transmitted Diseases August 20-21, 2018 Toronto, Canada; 2nd International Conference on Sexually Transmitted Diseases, Infections and AIDS Oct 17-18, 2018 Las Vegas, USA; 2nd International Conference on Worldwide Infectious Diseases November 19-20, 2018 Orlando, USA

Track 02: Causes and Symptoms of Infectious Diseases

Infectious diseases can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms common to many infectious diseases include fever, diarrhea, fatigue and muscle aches.

Related Conferences:

Track 03: Problems in infectious disease practice

Infection Control in a health care facility is prevention of the spread of microorganisms from one individual to another individual to prevent these infectious diseases problems frequent hand washing, infection outbreak, water and food in hospital must be maintained.

Related Conferences:

Track 04: Pediatric Infectious Diseases/ Childhood Infectious Diseases

Pediatric infectious diseases/ childhood infectious diseases are the infectious diseases which are caused in children of different age groups. Pediatric infectious diseases specialist’s takes care of the infections occurring in children and the treatment methods vary for children from adults.

Related Conferences:

Track 5: Viral Infectious Diseases

Viruses are like hijackers. They invade normal living cells and use those cells to multiply and produce other viruses like themselves. This can kill, damage, or change the cells and make sick. Different viruses attack certain cells in your body such as your liver, respiratory system, or blood.

Related Conferences:

Track 6: Bacterial Infectious Diseases

Bacteria are microscopic single-celled organisms that live almost everywhere. Bacteria live in every climate and location on earth. Some are airborne while others live in water or soil. Bacteria live on and inside plants, animals, and people. The word "bacteria" has a negative connotation, but bacteria perform many vital functions for organisms and in the environment.

Related Conferences:

Track 7: Fungal Infectious Diseases

Fungal Infectious Diseases are often caused by fungi that are common in the environment. Most fungi are not dangerous, but some types can be harmful to health. Mild fungal skin diseases can look like a rash and are very common. Fungal diseases in the lungs are often similar to other illnesses such as the flu or tuberculosis. Some fungal infections like fungal meningitis and bloodstream infections are less common than skin and lung infections but can be deadly.

Related Conferences:

Track 8: Blood infectious Diseases

Germs can cause infection in human blood and diseases are known as blood borne pathogens. The most common and dangerous germs spread through blood within the hospital are viral hepatitis B and hepatitis c virus. These viruses cause infections and liver injury. This virus cause AIDS. Organisms such as bacteria, viruses, prions, and parasites will be transmitted through blood transfusions.

Related Conferences:

Track 9: Epidemiological Diseases

The infectious disease epidemiology encompasses domestic and global work on the epidemiology of emerging and re-emerging infections, global infectious disease threats, disease surveillance, disease detection, development of vaccines and other prevention methods, clinical trials, and the role of infectious pathogens in the pathogenesis of chronic non-communicable diseases such as cancer and cardiovascular disease. The broad range to search the novel pathogens using advanced molecular techniques to longitudinal population-based studies to define transmission dynamics and spectrum of disease and survival. Approaches are employed in an interdisciplinary fashion to define etiology, pathogenesis, transmission, and prevention/treatment potential.

Related Conferences:

Track 10: Global Markets on Infectious Diseases

Global market report of infectious diseases is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Related Conferences:

Track 11: Tropical Infectious Diseases

Tropical diseases encompass all diseases that occur solely in the tropics. In practice, the term is often taken to refer to infectious diseases that thrive in hot, humid conditions, such as malaria, leishmaniasis, schistosomiasis, onchocerciasis, lymphatic filariasis, Chagas disease, African trypanosomiasis, and dengue.

Related Conferences:

Track 12: STD And HIV infection

There are a number of infections and cancers that can develop in people who are living with HIV. There are infections that can be life threatening. These are also known as opportunistic infections. The more common life-threatening infections include a lung infection called Pneumocystis pneumonia (PCP), an eye infection caused by cytomegalovirus (CMV), a brain infection called toxoplasmosis, and a generalized infection called Mycobacterium avium complex (MAC). Cancers that are more common include Hodgkin’s lymphoma, lung cancer, skin cancer, anal cancer, cervical and vaginal cancer in women, and testicular and prostate cancer in men. These cancers can often be successfully treated if they occur in people with HIV who maintain healthy immune systems with HIV treatment.

Related Conferences:

Track 13: Infection, Immunity and Inflammation

An investigation of key characteristics of viruses, bacteria and other micro-organisms causing infections in humans. The mechanisms by which micro-organisms cause disease and evade the immune system are considered. It then explores the principle components of the immune system, describing the molecules and cells that protect against infection and cancer, and their contribution to innate and adaptive immune responses.

Related Conferences:

Track 14: Pharmacology and Infectious Diseases

Pandemic, epidemic and endemic infectious diseases are united by a common problem to identify potential pharmacological interventions to treat infections. The large numbers of emerging and neglected infectious diseases are badly affecting the poorest members of the global society; new ways are required to develop high productivity discovery systems that can be applied to a large number of pathogens. The basis for developing methods to prioritize a priori potential drug targets analyzes the pharmacological landscape of an infectious disease.

Related Conferences:

Track 15: Veterinary Infectious Diseases

These sciences are used to control human health through monitoring and control of zoonotic disease, infectious disease transmitted from non-human animals to humans, food safety, and indirectly through human applications from basic medical research food supply is through livestock health monitoring and treatment, and mental health by keeping pet’s healthy and long living. Veterinary scientists often collaborate with epidemiologists.

Related Conferences:

Track 16: Antimicrobials/ Antibiotics/ Antibacterial

Antimicrobials/ antibiotics/ antibacterial are the drugs used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Few antibiotics possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza and their inappropriate use allows the emergence of resistant organisms.

Related Conferences:

Track 17: Vaccines and Vaccination

Vaccines are the products that can produce immunity from a disease and can be administered through needle injections, by mouth and by aerosol. Vaccination is the injection of a killed or weakened organism that produces immunity in the body against that organism.

Related Conferences:

Track 18: Health Care - Infectious Diseases

The infections experience in health care settings has become more challenging. Most of the duty workers get exposed commonly to a variety of infectious diseases during the performance of their duties. The primary route of infections transmission is airborne, contact (direct and indirect) which involves the entry of infectious agents from infected individual to a susceptible individual through physical contact and Indirect contact transmission occurs by susceptible individual physical contact with contaminated items. Infection conference 2018 is going to be a platform to discuss microbes that cause illness and its awareness of exposure in the health care settings.

Related Conferences:

Track 19: Infectious Diseases Prevention, Control and Cure

Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. Aseptic technique is normally applied to prevent the infections caused by different means. Sterilization is another process of killing microorganisms by the application of heat. Disinfection is the process of killing harmful microorganisms. Some infectious diseases can be prevented by avoiding direct contact with the contagious person. Infections can also be controlled and prevented by creating public awareness on various infectious diseases and their outbreaks. Infections can be cured by various antimicrobials.

Related Conferences:

Track 20: Malaria

Malaria is a mosquito borne infectious disease affecting humans and other animals caused by parasitic protozoans (a group of single celled microorganisms) belonging to the plasmodium type. Malaria symptoms typically include fever, fatigue, vomiting and headaches which can be observed in 10-15 after being bitten by mosquito. In severe cases, it can cause yellow skin, seizures, comaor and even death.

Related Conferences:

Track 21: Laboratory Diagnosis – Infectious Diseases:

Most of the diseases have similar signs and symptoms but the samples of the infected host body fluid disclose the microbe cause the illness. However, the detection of microbes that causes infectious diseases plays key role in medical research.

Related Conferences:

Track 22: Bone Infection

A bone infection, also called osteomyelitis, can result when bacteria or fungi invade a bone. In children, bone infections most commonly occur in the long bones of the arms and legs. In adults, they usually appear in the hips, spine, and feet. Bone infections can happen suddenly or develop over a long period of time. If they’re not properly treated, bone infections can leave a bone permanently damaged.

Related Conferences:

Conference Series Conferences invites all the participants from all over the world to attend ‘Infectious Diseases Meet 2018’ which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions.

Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of Microbiology Especially Clinical and Diagnostic Microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases.Tetanus (500,000), Measles(1million),HIV/AIDS(1million),HepatitisB (1.1million), Malaria(2.1million), Diarrhea (3.1 million),Tuberculosis (3.1 million), Respiratory Infections (4.4 million).

Who should attend?

Microbiologists
Bacteriologists
Virologists
Parasitologists
Mycologists
Pathologists
Pharmacists
Epidemiologists
Dermatologists
Neurologist
Ophthalmologist
Cardiologist
Health Care Professionals

Why to attend?

With members from around the world focused on learning about Emerging Innovative Treatment & Therapeutic Techniques in Infectious Diseases, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct Presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World’s eminent speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Targeted Audience

Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
Infectious Diseases Researchers, Scientists, Faculties, Students
Infectious Diseases Associations and Societies
Medical Colleges
Pharmaceutical Companies and Industries
Medical Devices Manufacturing Companies
Drug Manufacturing Companies and Industries
Laboratory Technicians and Diagnostic Companies
Business Entrepreneurs and Industrialists
Training Institutes
Software Developing Companies
Data Management Companies

For Scientific Sessions please go through the link: https://infectiousmeet.conferenceseries.com/call-for-abstracts.php

For Abstract Submission please go through the link: https://infectiousmeet.conferenceseries.com/abstract-submission.php

Scope and Importance of Infection Diseases

Every year, lives are lost because of the spread of infections in hospitals. Health care workers can take steps to prevent the spread of infectious diseases. These steps are part of infection control. Infection prevention and control measures aim to ensure the protection of those who might be vulnerable to acquiring an infection both in the general community and while receiving care due to health problems, in a range of settings. The basic principle of infection prevention and control is hygiene. Healthcare personnel might need to take additional infection control steps if a PUI or patient with confirmed EVD has other conditions or illnesses caused by specific infectious diseases, such as tuberculosis. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Splashes to unprotected mucous membranes (for example, the eyes, nose, or mouth) are particularly hazardous. Procedures that can increase environmental contamination with infectious material or create aerosols should be minimized. healthcare personnel (HCP) refers all people, paid and unpaid, working in healthcare settings who have the potential for exposure to patients and/or to infectious materials, including body substances, contaminated medical supplies and equipment, contaminated environmental surfaces, or aerosols generated during certain medical procedures. HCP include, but are not limited to, physicians, nurses, nursing assistants, therapists, technicians, emergency medical service personnel, dental personnel, pharmacists, laboratory personnel, autopsy personnel, students and trainees, contractual personnel, home healthcare personnel, and people not directly involved in patient care (clerical, dietary, housekeeping, laundry, security, maintenance, billing, chaplains, and volunteers) but potentially exposed to infectious agents that can be transmitted to and from HCP and patients.

Why Tokyo (Japan)?

Japan is the second largest Life science market in the world after USA, Occupying about 10% of Market in each of the global drug and Medical devices market. According to Data monitor, the Japanese biotechnology market had total revenue of $ 43.3 Billion in 2013. By 2017, the market is expected to grow to $ 53.8 Billion.

The Japanese pharmaceutical market is the world’s second-largest, with 2013 sales estimated at $115 billion. Japan accounts for a little less than 10 percent of the global Pharma market, compared with 38.4 percent for the U.S. and 20.7 percent for Western Europe

The Japanese market is a promising region for proteomics companies, as a high amount of proteomics research is being conducted in the country.

Best Places to Visit in Japan:

The most visited places would be Tokyo, Kyoto, and Nara. Some other places with some frequent tourist sightseeing include Nikko, Kamakura, Hakone, Osaka, and Hiroshima.

However, the most visited places are not necessarily the best. There are many excellent places that are not on the tourist radar.

The Yaeyama Islands and Okinawa are also very beautiful but get a lot fewer tourists.

Worldwide Associations for Infectious Diseases

International Society for Infectious Diseases
Journal of the Japanese Association for Infectious Disease
Pediatric Infectious Diseases Society
Texas Infectious Disease Society
British Infection Association
Infectious Diseases Society of America
National Foundation for Infectious Diseases
Infectious Disease Association of California
Society of Infectious Diseases Pharmacists
Cambridge Infectious Diseases

Major Infectious Disease Societies around the Globe

European Society of Clinical Microbiology and Infectious Diseases
International Union of Microbiological Societies
Federation of Infection Societies
Canadian Society of Microbiologists
British Infection Association
Federation of European Microbiological Societies
Welsh Microbiology Association
Clinical Virology Network
American Society for Microbiology
Society for General Microbiology
Infectious Diseases Society of America

Members associated with Infectious Diseases

Centre for Infectious Diseases and Policy includes 218 members
Global Public Health is having 106913 members
Members Pediatric Infectious Disease and Immunology has 3291 members
European Society of Clinical Microbiology and Infectious Diseases has 3438 members
Infectious Diseases Society has 707 members

Universities related to Infectious Diseases

University of Cambridge
Kings College of London
London School of Hygiene and Tropical Medicine
Imperial College London
UCL Institute of Epidemiology and Health care
University of Sheffield
Pediatric Infectious Diseases Society
Columbia University
University of Maryland
Swedish Institute for Infectious Disease Control
Uppsala University
University of Gothenburg
University of Otego
Oslo University
University of Pittsburgh
Emory Health Sciences
Queensland University of Technology
University of Liverpool
University of Colorado Denver
Infectious Diseases Society of America
Medical College of Georgia at Georgia Regents University

Market Research on Infectious Diseases

The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014. The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market. Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014. Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2014.

Funding allotted for Infectious Diseases

The Centers for Disease Control and Prevention’s (CDC) Procurement and Grants Office (PGO) awards over 25,000 acquisition and assistance actions each year and obligates approximately $11 billion in federal funds. PGO aids in achieving CDC’s mission by quickly and effectively allocating funds to where they are needed. In its Pledge to the American People, CDC commits to be a diligent steward of the funds entrusted to the Agency. PGO ensures this pledge remains intact. To learn more about PGO, please review our FY 2014 Annual Report, Acquisition Snapshot, and Assistance Snapshot.

Global Prevalence of Infectious Diseases

The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012. Market growth looks promising; the overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%. The demographic transition is associated with an epidemiological transition in the causes and age of death. A predominant feature of this transition is a decrease in the number of deadly infections occurring during childhood. On the contrary, it is projected that, in 2020, three-quarters of all deaths in developing countries could be due to age-associated diseases. These are predominantly non-communicable diseases, such as cardiovascular disease, cancer, and diabetes. What is the role of infection in the death of elderly individuals? Statistics from the WHO suggest that, in Europe and the United States, ∼5% of the population >60 years old will die as a consequence of infection, compared with ∼20% in Africa. However, although this relative difference in the importance of infection as a cause of death in industrialized countries versus developing countries is certainly relevant, the absolute numbers should be regarded with caution. Indeed, although studies using death certificates to identify causes of death usually find a relatively low importance of infection in industrialized countries, autopsy studies suggest a much higher contribution of infections to the overall causes of death (20%–30%). In the developing world, the leading infectious causes of death are respiratory tract infections, diarrheal diseases, tuberculosis, malaria, and AIDS, which together represent >90% of deaths. The remaining 10% are due to tropical diseases and various other infections. In industrialized countries, respiratory tract infections, bloodstream infections, urinary tract infections, and infections of the digestive system represent 90% of infection-related deaths; other diseases such as tuberculosis, hepatitis B and C, diarrheal diseases, and AIDS represent nearly all of the remaining 10%. As already stated by Kalache in 1996, many infectious diseases “no longer kill but neither do they die”. This aphorism is also a reminder that the impact of infectious diseases should not only be measured by mortality rate, but also by morbidity and quality of life, particularly in the aging population. These parameters are much more difficult to assess objectively, but understanding them will be increasingly important in the future.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance. With the unique feedback from the event, Conference Series would like to announce the commencement of the “Global Experts Meeting on Infectious Diseases” to be held during August 06-07, 2018, at Tokyo, Japan.

Let us meet again @ Infectious Diseases Meet 2018

For more information please visit: https://infectiousmeet.conferenceseries.com/

Worldwide deaths due to Infectious Diseases

Infectious Diseases 2017 Past Conference Report

Sensing the raising importance of Infectious Diseases prevention, control, treatment and cure, Conference Series hosted 2^nd World Congress on Infectious Diseases (Infectious Diseases 2017), scheduled from August 21-23, 2016 in San Francisco, California, USA with a theme “Novel Treatment Methods for Infectious Diseases Prevention, Control and Cure”. The conference was successful in gathering eminent speakers from various reputed organizations and their paramount talks enlightened the gathering.

The pragmatic meet organized by Conference Series received generous response from the Editorial Board Members of Conference Series Journals as well as expertise from academia, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2017 from Conference Series. The conference was marked with the presence of renowned Speakers, Young Researchers, Students and Business Delegates driving the three-day event into the path of success with thought provoking keynote and plenary presentations.

The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

Infectious Diseases
Immunology of Infections
Treatment for Infectious Diseases
Infectious Diseases Prevention, Control and Cure
Vaccines and Vaccination
Immunology of Infections
Neuro Infectious Diseases
Diagnosis of Infectious Diseases
Antimicrobials/ Antibiotics/ Antibacterial
Resistance Tuberculosis
Malaria
Hepatitis
Global Trends in Emerging Infectious Diseases
Antibiotic Resistance

Infectious Diseases 2017 Proceedings

The conference was embarked with an opening ceremony followed by Keynote presentations, Workshop and a series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

1. Moderators

Dr. Stef Stienstra, Dutch Armed Forces / Royal Dutch Navy, Netherlands

2. Session Chairs

Dr. Michael D Geschwind, University of California, San Francisco, USA
Dr. Harpal S. Mangat, Howard College of Medicine, USA
Dr. Chris Whiteley, Rhodes University, Grahamstown, South Africa
Dr. Stef Stienstra, Dutch Armed Forces / Royal Dutch Navy, Netherlands
Dr. Eugénie Bergogne-Bérézin, Paris University, France

3. Poster Judges

Dr. Stef Stienstra, Dutch Armed Forces / Royal Dutch Navy, Netherlands
Dr. Chris Whiteley, Rhodes University, Grahamstown, South Africa

4. Keynote Presentations

Dr. Michael D Geschwind, University of California, San Francisco, USA
Dr. Michael Brady, Nationwide Children’s Hospital, USA
Dr. Harpal S. Mangat, Howard College of Medicine, USA
Dr. Chris Whiteley, Rhodes University, Grahamstown, South Africa
Dr. Stef Stienstra, Dutch Armed Forces / Royal Dutch Navy, Netherlands
Dr. Eugénie Bergogne-Bérézin, Paris University, France

5. Best Poster Awards

Title: Mitochondrial DNA copy number inau1 c Egyptian patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

Doaa I Hashad, clinical pathology department, Alexandria, Egypt

Conference Series offers its heartfelt appreciation to Societies and Organizations, Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference Series in supporting and making the conference a grandiose event.

Your rejoinder is our inspiration, keeping this motto in mind and being witnessed the triumph of Infectious Diseases 2016, Conference Series is delighted to announce the next event, "3^rd Annual Congress on Infectious Diseases" to be held during August 21-23, 2017, San Francisco, California, USA.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	September 03-04, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

Media Partners

Testimonials

It was my pleasure to be involved in the meeting
Kei Amemiya, US Army Medical Research Institute of Infectious Diseases, USA

I enjoyed the meeting
Mervat Kassem, Alexandria University, Egypt

It was a real pleasure to participate in this scientific meeting
Anna Goc, Dr. Rath Research Institute BV, USA

Thank you so much for the opportunity of learning with all the colleagues I met there.
Ana MarÃa Arnaiz GarcÃa, University Hospital MarquÃ©s De Valdecilla, Spain

Thank you very much for your excellent organization of Infectious Diseases conference. It was a great success.
Luke Hunt, Liverpool School of Tropical Medicine, UK

This Conference was one of the best and even brilliant I have ever attended. There was very nice to have a mix between theory, basic science, sharing best practices and practical recommendations. The quality of the panels was outstanding, and I think you arranged a great cross-section of topics!
Sergey Suchkov I M Sechenov First Moscow State Medical University, Russia

We would like to thank the Organizing Committee for the outstanding event. It was just excellent in all aspects. Congratulations
Mauricio Laerte Silva Joana de Gusmao Childrenâ€™s Hospital, Brazil

I learned a lot from your conference and love to chair or co- chair a session. I will help recruit speakers to the next meeting as an organizer member of the conference committee
Shabaan Abdallah University of Cincinnati, USA

Thank you for organizing this conference. My husband and I really enjoyed the scientific programme, the positive international atmosphere and the welcoming spirit. We do support the aim of the Conference Series LLC LTD. We will recommend your coming conferences to our colleagues. Best wishes and good luck with future work.
Ylva Vladic Stjernholm Karolinska University Hospital, Sweden

Global Experts Meeting on Infectious Diseases September 03-04, 2018 Tokyo,Japan

Recommended Global Infectious Diseases Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Infectious Diseases Meet 2018

Welcome Message
Infectious Diseases Meet 2018

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Useful Links

Special Issues

Testimonials

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Infectious Diseases Meet 2018

Welcome Message Infectious Diseases Meet 2018

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Useful Links

Special Issues

Testimonials

Welcome Message
Infectious Diseases Meet 2018